Bliss GVS Pharma
Bliss Gvs Pharma Performance
Day Range
- Low 91
- High 92.95
52 Week Range
- Low 69.2
- High 104
- Open Price91.5
- Previous Close91.4
- Volume161793
Start SIP in Bliss GVS Pharma
Start SIPBliss Gvs Pharma Investment Rating
-
Master Rating:
-
Bliss Gvs Pharma has an operating revenue of Rs. 722.45 Cr. on a trailing 12-month basis. An annual revenue de-growth of -1% needs improvement, Pre-tax margin of 14% is healthy, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 14% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 11% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 15 which is a POOR score indicating inconsistency in earnings, a RS Rating of 55 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 81 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 109 | 143 | 169 | 139 | 147 | 138 |
Operating Expenses Qtr Cr | 98 | 133 | 135 | 112 | 128 | 129 |
Operating Profit Qtr Cr | 11 | 11 | 33 | 27 | 19 | 9 |
Depreciation Qtr Cr | 5 | 4 | 4 | 4 | 4 | 3 |
Interest Qtr Cr | 1 | 5 | 1 | 2 | 2 | 2 |
Tax Qtr Cr | 3 | 2 | 11 | 10 | 7 | 7 |
Net Profit Qtr Cr | 7 | 6 | 29 | 25 | 25 | 9 |
Bliss Gvs Pharma Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 5
- Bearish Moving Average
- ___
- 11
- 20 Day
- ₹94.31
- 50 Day
- ₹92.48
- 100 Day
- ₹88.17
- 200 Day
- ₹84.13
- 20 Day
- ₹95.58
- 50 Day
- ₹94.96
- 100 Day
- ₹85.93
- 200 Day
- ₹80.27
Bliss Gvs Pharma Resistance and Support
Resistance | |
---|---|
First Resistance | ₹92.84 |
Second Resistance | ₹93.87 |
Third Resistance | ₹94.79 |
RSI | 43.99 |
MFI | 28.5 |
MACD Single Line | 0.31 |
MACD | -0.36 |
Support | |
---|---|
First Resistance | ₹90.89 |
Second Resistance | ₹89.97 |
Third Resistance | ₹88.94 |
Bliss Gvs Pharma Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 189,061 | 8,991,741 | 47.56 |
Week | 235,443 | 13,549,716 | 57.55 |
1 Month | 349,194 | 16,618,163 | 47.59 |
6 Month | 334,786 | 16,679,057 | 49.82 |
Bliss Gvs Pharma Result Highlights
Bliss GVS Pharma Synopsis
NSE-Medical-Generic Drugs
Bliss Gvs Pharma is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 598.34 Cr. and Equity Capital is Rs. 10.42 Cr. for the Year ended 31/03/2023. Bliss GVS Pharma Ltd. is a Public Limited Listed company incorporated on 11/12/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1984PLC034771 and registration number is 034771.Market Cap | 958 |
Sales | 560 |
Shares in Float | 6.79 |
No of funds | 24 |
Yield | 0.54 |
Book Value | 1.02 |
U/D Vol ratio | 2 |
LTDebt / Equity | 4 |
Alpha | 0.04 |
Beta | 0.56 |
Bliss GVS Pharma
Owner Name | Jun-23 | Mar-23 | Dec-22 | Sep-22 |
---|---|---|---|---|
Promoters | 35.12% | 35.04% | 34.46% | 34.55% |
Mutual Funds | ||||
Insurance Companies | 6.62% | 6.63% | 6.63% | 6.64% |
Foreign Portfolio Investors | 16.5% | 16.6% | 16.53% | 16.68% |
Individual Investors | 30.1% | 30.01% | 30.73% | 30.57% |
Others | 11.66% | 11.72% | 11.65% | 11.56% |
Bliss GVS Pharma Management
Name | Designation |
---|---|
Mr. S R Vaidya | Chairman & Ind.Director |
Mr. Gagan Harsh Sharma | Managing Director |
Dr. Vibha Gagan Sharma | Whole Time Director |
Mrs. Shruti Vishal Rao | Whole Time Director |
Mr. Santosh L Parab | Independent Director |
Mrs. Shilpa Bhatia | Independent Woman Director |
Bliss Gvs Pharma Forecast
Price Estimates
Bliss Gvs Pharma Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-08-01 | Quarterly Results | |
2023-05-11 | Audited Results & Final Dividend | |
2023-01-24 | Quarterly Results | |
2022-11-07 | Quarterly Results | |
2022-08-03 | Quarterly Results |
- Company Name
- CMP
- Chg(%)
- Adani Ports
- 831
- 1.6
- Tech Mahindra
- 1292
- 1.4
- Dr Reddys Labs
- 5669
- 1.0
- Asian Paints
- 3244
- 0.9
- Bharti Airtel
- 918
- 0.8
- Company Name
- CMP
- Chg(%)
Bliss GVS Pharma FAQs
What is Share Price of Bliss GVS Pharma ?
Bliss GVS Pharma share price is ₹91 As on 22 September, 2023 | 08:06
What is the Market Cap of Bliss GVS Pharma ?
The Market Cap of Bliss GVS Pharma is ₹958.4 Cr As on 22 September, 2023 | 08:06
What is the P/E ratio of Bliss GVS Pharma ?
The P/E ratio of Bliss GVS Pharma is 16 As on 22 September, 2023 | 08:06
What is the PB ratio of Bliss GVS Pharma ?
The PB ratio of Bliss GVS Pharma is 1 As on 22 September, 2023 | 08:06